ITGA5 and liver cancer: Our study also found that EMP2 downregulation led to a significant reduction in ITGA5 protein expression, weakening the invasion ability of liver cancer cells and resulting in fewer and smaller experimental lung metastases; conversely, overexpression had the opposite effect.